School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
Department of Education and Sports Science, University of Stavanger, Stavanger, Norway.
Eur Eat Disord Rev. 2022 May;30(3):250-266. doi: 10.1002/erv.2891. Epub 2022 Feb 15.
The primary aim was to assess the feasibility of undertaking a study evaluating the novel Motivational and Psycho-Educational Self-Help Programme for Athletes with Mild Eating Disorder Symptoms (MOPED-A). A mixed-methods approach was adopted to explore the feasibility of recruiting and retaining participants, and to evaluate the acceptability of measures, procedures and the intervention. A secondary aim was to explore the potential efficacy of MOPED-A in reducing athletes' eating disorder symptoms.
Thirty-five athletes were recruited. Participation involved completing MOPED-A over a 6-week period and completing self-report measures at baseline (T1), post-intervention (T2) and 4-week follow-up (T3). A subsample (n = 15) completed an interview at T2.
Retention was good throughout the study (n = 28; 80%). Quantitative and qualitative feedback suggested the format, delivery, content and dosage of MOPED-A were acceptable. Athletes valued that the intervention was tailored to them, and this facilitated both participation and completion. Over a third of participants reported disclosing their eating difficulties and deciding to seek further support. Large reductions in eating disorder symptoms were detected at T2 and sustained at T3.
The MOPED-A intervention can be feasibly implemented, is acceptable to participants, and demonstrates potential for reducing symptoms in athletes. A larger, controlled trial is warranted.
本研究的主要目的是评估开展一项评估针对轻度饮食障碍症状运动员的新型动机和心理教育自助方案(MOPED-A)的可行性。本研究采用混合方法来探索招募和保留参与者的可行性,并评估措施、程序和干预的可接受性。次要目的是探索 MOPED-A 降低运动员饮食障碍症状的潜在疗效。
共招募了 35 名运动员。参与研究需要在 6 周内完成 MOPED-A,并在基线(T1)、干预后(T2)和 4 周随访(T3)时完成自我报告量表。亚组(n=15)在 T2 时完成访谈。
整个研究过程中保留率良好(n=28;80%)。定量和定性反馈表明,MOPED-A 的格式、交付、内容和剂量是可接受的。运动员认为该干预方案是为他们量身定制的,这促进了他们的参与和完成。超过三分之一的参与者报告透露了他们的饮食困难,并决定寻求进一步的支持。在 T2 时检测到饮食障碍症状大幅减少,并在 T3 时持续减少。
MOPED-A 干预措施是可行的,参与者接受度高,且具有降低运动员症状的潜力。需要进行更大规模的对照试验。